DE69403961T3 - Verfahren zur bestimmung der von blutplättchen abstammenden mikrovesikel - Google Patents

Verfahren zur bestimmung der von blutplättchen abstammenden mikrovesikel

Info

Publication number
DE69403961T3
DE69403961T3 DE69403961T DE69403961T DE69403961T3 DE 69403961 T3 DE69403961 T3 DE 69403961T3 DE 69403961 T DE69403961 T DE 69403961T DE 69403961 T DE69403961 T DE 69403961T DE 69403961 T3 DE69403961 T3 DE 69403961T3
Authority
DE
Germany
Prior art keywords
pct
microvesicles
determining
blood plates
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69403961T
Other languages
English (en)
Other versions
DE69403961D1 (de
DE69403961T2 (de
Inventor
Nils Solum
Frank Brosstad
Pal Holme
Geir Gogstad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Products GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69403961(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE69403961D1 publication Critical patent/DE69403961D1/de
Publication of DE69403961T2 publication Critical patent/DE69403961T2/de
Application granted granted Critical
Publication of DE69403961T3 publication Critical patent/DE69403961T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicinal Preparation (AREA)
  • Holo Graphy (AREA)
  • Telephone Function (AREA)
DE69403961T 1993-03-24 1994-03-23 Verfahren zur bestimmung der von blutplättchen abstammenden mikrovesikel Expired - Lifetime DE69403961T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306053A GB9306053D0 (en) 1993-03-24 1993-03-24 Method and assay
PCT/GB1994/000592 WO1994022018A1 (en) 1993-03-24 1994-03-23 Method and assay

Publications (3)

Publication Number Publication Date
DE69403961D1 DE69403961D1 (de) 1997-07-31
DE69403961T2 DE69403961T2 (de) 1998-01-02
DE69403961T3 true DE69403961T3 (de) 2003-01-16

Family

ID=10732620

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69403961T Expired - Lifetime DE69403961T3 (de) 1993-03-24 1994-03-23 Verfahren zur bestimmung der von blutplättchen abstammenden mikrovesikel

Country Status (13)

Country Link
US (1) US5811250A (de)
EP (1) EP0694168B2 (de)
JP (1) JP3422491B2 (de)
AT (1) ATE154847T1 (de)
AU (1) AU691489B2 (de)
CA (1) CA2158363C (de)
DE (1) DE69403961T3 (de)
DK (1) DK0694168T4 (de)
ES (1) ES2103582T5 (de)
FI (1) FI113206B (de)
GB (1) GB9306053D0 (de)
NO (1) NO953770L (de)
WO (1) WO1994022018A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
NO20031431D0 (no) * 2003-03-28 2003-03-28 Forskningsparken As Metode for å diagnostisere hemostatiske forstyrrelser ved bruk av mikrovesikler fra blodplater
ES2571929T3 (es) * 2004-05-26 2016-05-27 Region Nordjylland Procedimiento para determinar la cantidad de CD36 circulante
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2006088976A2 (en) * 2005-02-16 2006-08-24 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
CN101627135B (zh) * 2007-02-05 2013-04-10 北日德兰大区 通过测量cd36诊断动脉粥样硬化斑块的方法
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
CN102084000B (zh) * 2008-02-01 2016-03-16 总医院有限公司 微泡在医学疾病和病况的诊断、预后以及治疗中的用途
IT1398680B1 (it) * 2009-06-12 2013-03-08 Bios Internat S R L Metodo in vitro per la determinazione della proteina gp91phox come marker di stress ossidativo
WO2011031877A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
WO2011031892A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011063324A2 (en) * 2009-11-20 2011-05-26 The General Hospital Corporation Microfluidic systems for isolating microvesicles
WO2011084791A2 (en) 2009-12-21 2011-07-14 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-vegf treatment
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
JP2013526852A (ja) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
WO2012064993A1 (en) 2010-11-10 2012-05-18 Exosome Diagnosties, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
US11143659B2 (en) 2015-01-27 2021-10-12 Arterez, Inc. Biomarkers of vascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities

Also Published As

Publication number Publication date
GB9306053D0 (en) 1993-05-12
AU6262794A (en) 1994-10-11
NO953770D0 (no) 1995-09-22
ATE154847T1 (de) 1997-07-15
ES2103582T5 (es) 2002-12-16
FI113206B (fi) 2004-03-15
CA2158363A1 (en) 1994-09-29
DE69403961D1 (de) 1997-07-31
EP0694168A1 (de) 1996-01-31
CA2158363C (en) 2004-08-17
EP0694168B1 (de) 1997-06-25
WO1994022018A1 (en) 1994-09-29
DK0694168T3 (da) 1997-07-21
JP3422491B2 (ja) 2003-06-30
US5811250A (en) 1998-09-22
FI954499A (fi) 1995-09-22
FI954499A0 (fi) 1995-09-22
DE69403961T2 (de) 1998-01-02
DK0694168T4 (da) 2002-09-30
EP0694168B2 (de) 2002-06-12
NO953770L (no) 1995-09-22
ES2103582T3 (es) 1997-09-16
AU691489B2 (en) 1998-05-21
JPH08509806A (ja) 1996-10-15

Similar Documents

Publication Publication Date Title
DE69403961T3 (de) Verfahren zur bestimmung der von blutplättchen abstammenden mikrovesikel
DE69317289D1 (de) Verfahren zur diagnose und zur überprüfung von sepsis
DE69623234D1 (de) Systeme und methoden zur vorherbestimmung von parametern bei der behandlung von blut
DE69603491D1 (de) Reagenz und verfahren zur differentiellen bestimmung von leukocyten im blut
DE69729473D1 (de) Pharmazeutisch-genetische verfahren zur verwendung bei der behandlung von krankheiten des nervensystems
DE3874530D1 (de) Untersuchung des abbaus von kollagen typ iii.
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
DE69022425D1 (de) Verfahren zur Bestimmung der funktionellen Wirkung von freiem Protein S oder Protein C in einer Plasmaprobe.
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
DK0791073T3 (da) Analysemetode
DE69911417D1 (de) Verfahren zur diagnose von gefässerkrankungen und früher atheriosklerose
DE69018840D1 (de) Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes.
ATE136940T1 (de) Diagnostische methode
EP0870036A4 (de) Synthetische säugetier alpha-n-aectylglukosaminidase und dafür kodierende genetische sequenzen
ATE80465T1 (de) Diagnose von fettleibigkeit, hervorgerufen durch eine genetische abnormalitaet, und verfahren zur therapeutischen behandlung von genetisch bedingter fettleibigkeit.
DE69526490T2 (de) Verfahren und vorrichtung zur in erster linie ambulanten erfassung von verdauungsparametern
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
ATE423504T1 (de) Verfahren zur echtzeit-überwachung des gesundheitszustandes und des behandlungsplans von patienten
ATE81726T1 (de) Verfahren und test-kit zur semiquantitativen bestimmung des kalziumgehaltes im blut.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: SOLUM, NILS OLAV, NESODDTANGEN, NO BROSSTAD, FRANK

8366 Restricted maintained after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: DADE BEHRING MARBURG GMBH, 35041 MARBURG, DE

8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, , DE